Skip to main content
Top
Published in: Lung 4/2005

01-08-2005

Development of Microscopic Polyangiitis in Patients with Chronic Airway Disease

Authors: K. Takahashi, S. Hayashi, O. Ushiyama, N. Sueoka, M. Fukuoka, K. Nagasawa

Published in: Lung | Issue 4/2005

Login to get access

Abstract

Microscopic polyangiitis (MPA) is a rare systemic vasculitis syndrome, which is often accompanied by positive myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA). While pulmonary involvement of MPA consists mainly of diffuse alveolar hemorrhage and interstitial pneumonia, bronchiectasis has been reported as a pulmonary lesion in association with MPA. To investigate the clinical features of patients with MPA, focusing on the presence or the absence of preceding chronic airway diseases (CAD), we conducted a retrospective observational study of 26 patients in the last 13 years at Saga University Hospital. The clinical records and radiologic chest examinations were reviewed retrospectively. Pulmonary manifestations were alveolar hemorrhage in 3 patients (12%) and interstitial pneumonia in 5 (19%). Bronchiectasis, defined by the findings of chest radiograph and computed tomography, was found in 9 patients (35%). Four patients (15%) with bronchiectasis and one patient (4%) with chronic bronchitis had experienced chronic bronchial suppuration prior to the onset of MPA. Ten patients were classified as having chronic airway disease (CAD) before the onset of MPA. MPO-ANCA tended to be lower in the CAD group than in the non-CAD group. None of the patients in the CAD group had pulmonary hemorrhage or interstitial pneumonia. Only one patient (10%) in the CAD group died within 90 days of the onset of MPA, while 7 (43.8%) of the non-CAD group died. Our study suggests that MPA may result in part from CAD and that the clinical course of MPA with CAD may be different from MPA without CAD.
Literature
1.
go back to reference Fraser, RS, Muller, NL, Colman, N, Pare, PD 1999Diagnosis of disease of the chest4WB SaundersDarien, IL22722277 Fraser, RS, Muller, NL, Colman, N, Pare, PD 1999Diagnosis of disease of the chest4WB SaundersDarien, IL22722277
2.
go back to reference Hilton, AM, Doyle, L 1978Immunological abnormalities in bronchiectasis with chronic bronchial suppurationBr J Dis Chest72207216CrossRefPubMed Hilton, AM, Doyle, L 1978Immunological abnormalities in bronchiectasis with chronic bronchial suppurationBr J Dis Chest72207216CrossRefPubMed
3.
go back to reference Hilton, AM, Hasleton, PS, Bradlow, A, Leahy, BC, Cooper, KM, Moore, M 1984Cutaneous vasculitis and immune complex in severe bronchiectasisThorax39185191PubMed Hilton, AM, Hasleton, PS, Bradlow, A, Leahy, BC, Cooper, KM, Moore, M 1984Cutaneous vasculitis and immune complex in severe bronchiectasisThorax39185191PubMed
4.
go back to reference Horan, MA, Leahy, BC, Fox, RA, Stretton, TB, Haeney, M 1984Immunological abnormalities in patients with chronic bronchial suppuration: a possible relationship with endotoxaemiaBr J Dis Chest786674PubMed Horan, MA, Leahy, BC, Fox, RA, Stretton, TB, Haeney, M 1984Immunological abnormalities in patients with chronic bronchial suppuration: a possible relationship with endotoxaemiaBr J Dis Chest786674PubMed
5.
go back to reference Jennette, JC, Falk, RJ, Andrassy, K, Bacon, PA, Churg, J, Gross, WL, et al. 1994Nomenclature of systemic vasculitides. Proposal of an international consensus conferenceArthritis Rheum37187192PubMed Jennette, JC, Falk, RJ, Andrassy, K, Bacon, PA, Churg, J, Gross, WL,  et al. 1994Nomenclature of systemic vasculitides. Proposal of an international consensus conferenceArthritis Rheum37187192PubMed
6.
go back to reference Matsuyama, W, Wakimoto, J, Watanabe, A, Kubota, I, Hirotsu, Y, Mizoguchi, A, et al. 1999Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodyIntern Med38813816PubMed Matsuyama, W, Wakimoto, J, Watanabe, A, Kubota, I, Hirotsu, Y, Mizoguchi, A,  et al. 1999Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodyIntern Med38813816PubMed
7.
go back to reference Nagata, T, Hara, K, Oka, T, Yamaguchi, Y, Igarashi, K, Hazama, H, et al. 2001Microscopic polyangitis associated with sinobronchial syndromeIntern Med40544547PubMed Nagata, T, Hara, K, Oka, T, Yamaguchi, Y, Igarashi, K, Hazama, H,  et al. 2001Microscopic polyangitis associated with sinobronchial syndromeIntern Med40544547PubMed
8.
go back to reference Nakanishi, M 1984BronchiectasisKokyu314981503 Nakanishi, M 1984BronchiectasisKokyu314981503
9.
go back to reference Sitara, D, Hoffbrand, BI 1990Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitisPostgrad Med J66669671PubMed Sitara, D, Hoffbrand, BI 1990Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitisPostgrad Med J66669671PubMed
10.
go back to reference Sugiyama, Y, Kitamura, S 1999Antineutrophil cytoplasmic antibodies in diffuse panbronchiolitisRespiration66233235CrossRefPubMed Sugiyama, Y, Kitamura, S 1999Antineutrophil cytoplasmic antibodies in diffuse panbronchiolitisRespiration66233235CrossRefPubMed
11.
go back to reference Swartz, MN 1990BronchiectasisFishman, AP eds. Pulmonary diseases and disordersMcGraw-HillNew York15531580 Swartz, MN 1990BronchiectasisFishman, AP eds. Pulmonary diseases and disordersMcGraw-HillNew York15531580
12.
go back to reference Tanaka, E, Tada, K, Amitani, R, Kuze, F 1992Systemic hypersensitivity vasculitis associated with bronchiectasisChest102647649PubMed Tanaka, E, Tada, K, Amitani, R, Kuze, F 1992Systemic hypersensitivity vasculitis associated with bronchiectasisChest102647649PubMed
13.
go back to reference Xiao, H, Heeringa, P, Hu, P, Liu, Z, Zhao, M, Aratani, Y, et al. 2002Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in miceJ Clin Invest110955963CrossRefPubMed Xiao, H, Heeringa, P, Hu, P, Liu, Z, Zhao, M, Aratani, Y,  et al. 2002Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in miceJ Clin Invest110955963CrossRefPubMed
Metadata
Title
Development of Microscopic Polyangiitis in Patients with Chronic Airway Disease
Authors
K. Takahashi
S. Hayashi
O. Ushiyama
N. Sueoka
M. Fukuoka
K. Nagasawa
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Lung / Issue 4/2005
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-004-2540-1

Other articles of this Issue 4/2005

Lung 4/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine